A detailed history of Maryland State Retirement & Pension System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Maryland State Retirement & Pension System holds 6,027 shares of REGN stock, worth $4.29 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,027
Previous 8,146 26.01%
Holding current value
$4.29 Million
Previous $8.56 Million 26.0%
% of portfolio
0.14%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $2.17 Million - $2.55 Million
-2,119 Reduced 26.01%
6,027 $6.34 Million
Q2 2024

Jul 30, 2024

BUY
$883.2 - $1071.19 $86,553 - $104,976
98 Added 1.22%
8,146 $8.56 Million
Q1 2024

Apr 19, 2024

BUY
$902.69 - $993.35 $61,382 - $67,547
68 Added 0.85%
8,048 $7.75 Million
Q3 2023

Oct 23, 2023

BUY
$692.45 - $844.37 $45,009 - $54,884
65 Added 0.82%
7,980 $6.57 Million
Q2 2023

Jul 10, 2023

SELL
$700.03 - $830.35 $203,708 - $241,631
-291 Reduced 3.55%
7,915 $5.69 Million
Q1 2023

Apr 20, 2023

BUY
$680.49 - $826.97 $33,344 - $40,521
49 Added 0.6%
8,206 $6.74 Million
Q4 2022

Jan 17, 2023

BUY
$705.89 - $766.39 $5.76 Million - $6.25 Million
8,157 New
8,157 $0
Q2 2022

Aug 01, 2022

BUY
$548.35 - $738.84 $42,222 - $56,890
77 Added 0.97%
7,986 $4.72 Million
Q1 2022

Apr 11, 2022

BUY
$595.12 - $698.43 $157,706 - $185,083
265 Added 3.47%
7,909 $5.52 Million
Q3 2021

Oct 29, 2021

BUY
$574.03 - $680.96 $85,530 - $101,463
149 Added 1.99%
7,644 $4.68 Million
Q2 2021

Jul 13, 2021

BUY
$472.8 - $558.54 $39,242 - $46,358
83 Added 1.12%
7,495 $4.36 Million
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $2.61 Million - $3.2 Million
5,844 Added 372.7%
7,412 $3.51 Million
Q4 2020

Feb 04, 2021

BUY
$478.3 - $607.98 $749,974 - $953,312
1,568 New
1,568 $805,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.